Better Medicine Secures €6M in Funding for AI-Powered Radiology Solutions
Better Medicine, an innovative AI-driven diagnostic startup, has successfully raised €6M ($6.89M) in total funding, including a recent pre-seed round of €1M ($1.1M) led by Soulmates Ventures. This follows a €2.5M ($2.9M) grant from the European Innovation Council, strengthening its financial foundation for a robust commercial rollout across Europe. The company addresses a critical radiology crisis, with 50% of UK radiology jobs unfilled, by providing clinically validated AI tools that enhance detection, measurement, and reporting of oncological findings in CT scans. Its flagship product, BMVision Kidney, is now CE-certified as a Class IIa medical device, demonstrating impressive efficacy with 99.2% detection rates and 52% time savings for radiologists. Headquartered in Tartu, Estonia, Better Medicine aims for FDA clearance and plans to expand its portfolio to cover more organs while launching clinical pilots in the U.S., ensuring optimal cancer detection and easing clinician workloads.
